Simon X Benito Inovio Pharmaceuticals, Inc. (INO) insider trading activity

Simon X Benito is Director of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 10,024 shares of INO, which is worth approximately $18,444. The most recent transaction as insider was on May 15, 2024, when has been sold 2,166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K

0% 3M change

89.37% 12M change

Total Value Held $18,444

SIMON X BENITO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	BUY Exercise of conversion of derivative security	-	2,166 Added 17.77%	10,024 Common Stock
May 16 2023	BUY Exercise of conversion of derivative security	-	19,000 Added 16.77%	94,305 Common Stock
Jul 20 2022	SELL Open market or private sale	$4,500 $2.25 p/Share	2,000 Reduced 2.59%	75,305 Common Stock
Jul 20 2022	BUY Exercise of conversion of derivative security	$4,400 $2.2 p/Share	2,000 Added 2.52%	77,305 Common Stock
May 13 2022	BUY Exercise of conversion of derivative security	-	18,000 Added 19.29%	75,305 Common Stock
Mar 16 2022	SELL Open market or private sale	$6,320 $3.16 p/Share	2,000 Reduced 3.37%	57,305 Common Stock
Mar 16 2022	BUY Exercise of conversion of derivative security	$4,400 $2.2 p/Share	2,000 Added 3.26%	59,305 Common Stock
Jan 19 2022	SELL Open market or private sale	$8,540 $4.27 p/Share	2,000 Reduced 3.37%	57,305 Common Stock
Jan 19 2022	BUY Exercise of conversion of derivative security	$4,400 $2.2 p/Share	2,000 Added 3.26%	59,305 Common Stock
May 17 2021	SELL Open market or private sale	$20,158 $6.62 p/Share	3,045 Reduced 5.05%	57,305 Common Stock
May 14 2021	BUY Exercise of conversion of derivative security	-	8,700 Added 12.6%	60,350 Common Stock
Apr 16 2021	SELL Open market or private sale	$17,500 $8.75 p/Share	2,000 Reduced 3.73%	51,650 Common Stock
Apr 16 2021	BUY Exercise of conversion of derivative security	$7,120 $3.56 p/Share	2,000 Added 3.59%	53,650 Common Stock
Mar 16 2021	SELL Open market or private sale	$20,820 $10.41 p/Share	2,000 Reduced 3.73%	51,650 Common Stock
Mar 16 2021	BUY Exercise of conversion of derivative security	$7,120 $3.56 p/Share	2,000 Added 3.59%	53,650 Common Stock
Feb 16 2021	SELL Open market or private sale	$29,360 $14.68 p/Share	2,000 Reduced 3.73%	51,650 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$7,120 $3.56 p/Share	2,000 Added 3.59%	53,650 Common Stock
Jan 04 2021	SELL Open market or private sale	$24,750 $9.0 p/Share	2,750 Reduced 5.06%	51,650 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$9,790 $3.56 p/Share	2,750 Added 4.81%	54,400 Common Stock

Also insider at

DRRX

DURECT CORP Healthcare

Director

SXB

Simon X Benito

Director

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account